Erdafitinib for the treatment of urothelial cancer

Marandino, L; Raggi, D; Giannatempo, P; Fare, E; Necchi, A

Marandino, L (reprint author), Fdn IRCCS Ist Nazl Tumori, Milan, Italy.

EXPERT REVIEW OF ANTICANCER THERAPY, 2019; 19 (10): 835

Abstract

Introduction: Fibroblast growth-factor receptor (FGFR) inhibition is a promising strategy of treatment in urothelial cancer (UC). FGFR3 mutations or f......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索